Healthcare · Pricing Negotiation Call

Healthcare Pricing Negotiation Script: Holding Your Number After the CMIO Has Already Chosen You

You've already won this. Their informatics analyst built the SMART on FHIR launch in the test environment, fourteen docs across family medicine, ortho and behavioral health ran it for six weeks, and the audit log says after-hours EHR time on that cohort went from 94 minutes a provider per day to 38. The Director of Clinical Informatics told the CMIO it's the pick. The CMIO told the Medical Group President. Now you're on a call with the CMIO, the VP of Clinical Operations, and — the tell — someone from supply chain or value analysis who has never been on a call with you before.

Nothing on this call is about whether the product works. Every single thing on this call is about the number. And healthcare buyers are extraordinarily good at this, because they negotiate hard against Cardinal, Medtronic and their own EHR vendor every quarter, and because they can say "our operating margin is 1.8%" and be telling the absolute truth while also using it as a lever. They'll be warm about it. They'll call you by your first name. They'll dangle a HIMSS case study and a peer-CMIO reference like they're handing you a gift, and then go quiet after naming a per-provider-per-month figure that's half your quote.

The trap is that it never feels like a fight, so you never fight it — you just make six reasonable-sounding concessions in forty minutes and end up 30 points down with nothing back and no signature date. This healthcare pricing negotiation script gives you the frame, the trade list, the exact language for the five tactics they'll run, and a way to say no warmly enough that they still want to be your reference in Q3.

The pricing negotiation call script

Say it in your own words. The structure is the part that matters.

  1. 1

    Before you dial — write down three numbers and a trade list

    Do not join this call without these on a sticky note. **Ask:** what's on the quote. Example used throughout: 340 providers at $150 per provider per month = $612K annual. **Target:** where you honestly expect to land. Call it $132 PPPM / ~$539K, tied to a 36-month term. **Floor:** the number that needs your VP's signature, and separately the number where you genuinely walk. If you don't set the floor before the call, the floor becomes wherever the CMIO stops pushing. **What you can give:** discount points, waived implementation, a deferred start aligned to their credentialing calendar (90–120 days per provider anyway), ramped go-live waves by specialty, extra sandbox, net-45, a renewal uplift cap. **What you take in exchange:** 36-month term, annual prepay, enterprise scope instead of one pod, a named case study with a spokesperson and a date, two peer reference calls to CMIOs on their EHR, a clean MSA (no uncapped liability rewrite), signature by a date, and an introduction to the sister region or the affiliated FQHC network. Rule: nothing leaves the left column without something specific coming back from the right. Not "let me see what I can do." A named counter-item, every time.

  2. 2

    Opening — make them re-state the yes before they anchor

    "Before we get into commercials — Dr. Reyes, last week you said the informatics team and Maria's ops group are aligned that this is the direction. Just so I'm building the right paper: is that still where you are?" Wait for the yes. Get it out loud, in front of supply chain. It is much harder to threaten to restart an evaluation twenty minutes after confirming you finished one. Then: "Great. Then the only thing left is structure and number, so let's spend the time there."

  3. 3

    Restate the business case in their numbers, not yours

    "Here's the shape of it as your team measured it, not as I pitched it. Fourteen providers in the pilot, six weeks. After-hours EHR time went from 94 minutes a provider a day to 38 — your audit log, not my dashboard. Your internal target is under 30, so you're within striking distance for the first time since the Epic conversion. Chart closure inside 24 hours went from 61% to 88% on that cohort, which Nancy's revenue cycle team said is what's been driving the medical-necessity denials. "And the number none of us can prove but all of us believe: you told me you're running about 12% physician turnover and that replacing one family medicine doc is six figures in recruiting plus 12 to 18 months of panel ramp. "The proposal on the table is $612K a year across 340 providers. That's the ratio we're negotiating against. So — what needs to happen to get this signed?" You are not justifying the price. You're setting the denominator before they set the numerator.

  4. 4

    Tactic 1 — the low anchor: "We budgeted about half that"

    Do not counter. Do not flinch. Get curious about the construction of the number. "Help me understand how you got to $300K — is that a line finance has already approved for this fiscal year, or is it what you'd like it to be?" That distinction is the entire deal. Half the time "we budgeted half" means "we budgeted before we scoped the specialty rollout," or "I have $300K in FY25 and the rest sits in the FY26 physician retention line." If the number is genuinely real, move **scope**, never price alone: "I can build you something at $300K. It won't be this. It's 150 providers — primary care and family medicine only — no ortho, no derm, no behavioral health, and behavioral health is where your no-show rate and your worst charting burden both live. Do you want me to price that version, or do we work together on how to fund the full 340?" That is the single most important move on this call. When they push price, you move scope.

  5. 5

    Tactic 2 — the competitor quote and the "Epic is building it" line

    Assume the quote is real. Assume it is not the same thing. "That's a real number and I believe you. Can you send me the quote? Not to match it — I want to see what's in it. Every time we've seen theirs it's priced per provider on the primary care template and the specialty models are a separate SKU, and the SMART on FHIR build is a professional services line that shows up as a change order in month four." Then the question that ends it: **"If they were free, would you still be buying them?"** Nine times out of ten, the CMIO says a version of "no, yours performed better in ortho." That answer is your leverage for the remaining thirty minutes. On the native EHR module: "They will ship it, and it'll be solid for a straightforward primary care note. Two honest questions. Which of your sites is actually in the release wave, and when — because when I've asked that at other systems the answer is three releases out. And what does it do for Dr. Okafor's ortho clinic and your behavioral health group, which is where your after-hours time is worst? Meanwhile you're asking your docs to charge through the next 18 months. That's the thing we're pricing." Never say the competitor is worse. Say what's not in the quote and what it costs.

  6. 6

    Tactic 3 — the case study and reference trade, priced properly

    They'll offer it like a favor. Treat it as currency and put a date on it. "I'd genuinely value that — a CMIO from a system your size on your EHR is worth more to me than a logo. So let's make it a real trade rather than a nice intention. Three points off in exchange for: your logo, a named quote from you, one recorded video inside 120 days of go-live, and two reference calls to peer CMIOs I'll queue up. Written into the order form. "Can you commit to that? And who has to approve it — does it go through marketing and comms, or does your general counsel touch anything with the system's name on it?" Most buyers who dangle a case study go quiet when you ask for a spokesperson and a deadline. If they can't commit, the three points come off the table — warmly. "Totally understood. Then let's keep it clean and leave that out of the number."

  7. 7

    Tactic 4 — the delay threat: "We may just push the PO to next fiscal year"

    Don't panic and don't buy the quarter with margin. Make them do the cost-of-delay math out loud. "That's your call and I'll still be here. Practically though — EHR governance meets monthly, so a July PO means an August committee slot, which means go-live in the fall. Two things I'd want you to weigh. Maria, your Q1 access targets were partly built on getting third-next-available down, and Dr. Reyes, you told me you have three docs in family medicine you're worried about losing this year. Does the retention case survive a six-month slip?" Then solve the actual problem, which is usually cash timing, not desire: "If it's budget-year mechanics rather than the decision itself, I can do a deferred start. Sign this month, first invoice July 1, go-live waves start with the primary care cohort in June so you're not paying for providers who aren't live yet. You keep this price, the spend lands in the right fiscal year, and your governance packet goes in on the current cycle." That costs you nothing and takes the threat off the table.

  8. 8

    Tactic 5 — the silence after they name a figure

    They say "we'd need to be at $95 per provider per month," and then they stop talking. This is where the margin leaks. **Rule: you may not improve your own offer twice in a row.** After the silence, you have exactly two legal moves — say nothing, or ask a question. Count to seven. Then: "...What's your reaction to where we are?" Or, if you must speak, speak about process rather than price: "What's the approval path once we've agreed the number — does this go to value analysis, or straight to the Medical Group President?" The pause was the tactic. Don't pay for it.

  9. 9

    The concession ladder — smaller, traded, explained

    Every step down must be smaller than the last, tied to something, and justified out loud. Step 1: "I can get to $138 — that's 8% — on a 36-month term. Credentialing and rollout waves take you nine months anyway; a 12-month term means we're renegotiating before half your specialties are live." Step 2: "$133.50, eleven points, if it's annual prepay rather than quarterly. That's the one I can actually defend internally." Step 3: "$132 — twelve — if the order form is signed by the 26th so it lands in our quarter. That's the end of the ladder." Bad: 15 → 20 → 25. You've taught them each ask is worth five points. Good: 8 → 11 → 12. Decreasing increments are how a floor sounds. And discount the implementation and enablement lines before the platform PPPM. Your renewal uplift conversation in year three is built off that per-provider baseline.

  10. 10

    Using your VP properly — buy a trade, not a stall

    "$110 is outside what I can sign. I can take it to my VP, but I can't walk in with just a request — I need to walk in with an argument. If it's 36 months, prepaid, all 340 providers rather than a 150-seat pilot, and your name on a case study, I have something to say. Give me that and I'll go fight for it." Use it once. Come back with a number that is clearly final and say *why* it's final: "He approved 12 because of the term and the prepay. He wouldn't go past it because it sets the floor for the two other systems we're papering on your EHR this quarter. That's the honest reason."

  11. 11

    Landing it — the signature path, said out loud

    "Let me play it back. $132 per provider per month, 340 providers, 36-month term, annual prepay with first invoice July 1, implementation fee waived, renewal uplift capped at 4%, case study and two peer CMIO reference calls inside 120 days of go-live, and you're signing by the 26th. Have I got that right? "On the path: who physically signs — you or the Medical Group President? Is legal engaged on the BAA and the MSA, or does that start when the order form lands? Third-party risk review — is that closed from the eval, or does it re-open at contract? And is there a PO to raise through supply chain, or does this sit under an existing agreement? "I'll have the revised order form to you inside the hour and I'll hold fifteen minutes Thursday to confirm legal's clear." Then the line that protects it: "And to be straight with you — this number is tied to those terms and that date. If the date moves, I have to take it back through approval. I'd rather tell you now than surprise you in three weeks."

  12. 12

    Staying warm the whole way through

    You are sitting on their side of the table arguing with your own company. Signal it constantly: "I want to get this done." "Let me see what I can build." "Give me an argument and I'll go fight for it." A firm no delivered warmly gets respected. A soft yes delivered nervously gets pushed a fourth time. CMIOs and supply chain leads negotiate for a living against device reps and EHR vendors — they genuinely enjoy negotiating with someone who's also good at it, and your composure is what stops the next ask.

How the call actually sounds

Prospect on the left, the rep on the right.

  1. Rep

    Before we get into commercials — Dr. Reyes, last week you said informatics and Maria's ops group are aligned that this is the direction. Still where you are?

  2. Buyer

    It is. Your product performed best in the eval, I'm not going to pretend otherwise. But I have to tell you, Karen from supply chain pulled the quote apart and we're a long way off. Our operating margin last year was 1.8%. Six hundred and twelve thousand dollars for documentation software is not a number I can walk into the finance committee with.

  3. Rep

    Understood, and I'd rather have that conversation with Karen on the line than without her. Help me understand how you got to the number you can walk in with — is there an approved line for this in the current fiscal year, or is it a target you're working toward?

  4. Buyer

    There's about $300K sitting in the clinical technology line. And honestly, our benchmark is what the EHR is going to charge us. Their ambient module is coming next year and I've heard numbers in the seventy-to-eighty-dollar per provider per month range. So $150 looks like a lot.

  5. Rep

    That's a fair benchmark and I'm not going to argue with it. Two honest questions though. Which of your sites is actually in the release wave for that module, and when — because when I've asked that at three other systems on your EHR, nobody could tell me. And second: does it cover ortho and behavioral health at launch, or primary care first? Because Dr. Okafor's ortho group had the highest after-hours EHR time in your own audit pull.

  6. Buyer

    Primary care first, I assume. And no, I don't have a date for us. But that doesn't change my budget. Look — I'll be straightforward with you. We could get there at $95 a provider per month. I think that's a fair number for a system our size.

  7. Rep

    [pause, seven full seconds] ...What's driving the ninety-five specifically?

  8. Buyer

    It's what the other vendor came in at. And frankly it's what makes this fundable without going to the board.

  9. Rep

    Can you send me their quote? Not to match it — I want to see what's inside it. Every time we've seen that vendor, the specialty models are a separate SKU and the SMART on FHIR build is professional services, which shows up as a change order about four months in. But let me ask you the question that actually matters: if they were free, would you still be buying them?

  10. Buyer

    ...No. Your ortho notes were better and my docs said so in the survey. But you're not free, and I still have a $300K line.

  11. Rep

    Then let's work on the funding rather than pretending the scope is the same. Here's the thing I can do: I can build you a $300K version. That's roughly 150 providers, family medicine and internal medicine only, no ortho, no derm, no behavioral health. Do you want me to price that — or do we work out how to fund all 340, given the retention case is the part your Medical Group President actually cares about?

  12. Buyer

    Don't scope it down. If half the medical staff has it and half doesn't, I'll have a war on my hands and you'll have a dead pilot in month four — I've been through that with a scribe vendor already. But I need you to move. And I'll do this: I'll give you a case study. We'd be a good logo for you, we present at ViVE every year.

  13. Rep

    I'd genuinely value that — a CMIO on your EHR at your scale is worth more to me than most of my pipeline. So let me make it a real trade instead of a nice intention. Here's the structure. $138, eight points off, on a 36-month term — your credentialing alone runs 90 to 120 days a provider and the specialty waves take nine months, so a one-year term means we're renegotiating before half your medical group is even live. Then $133.50 if it's annual prepay rather than quarterly. And I'll take the last three points to $130 for the case study — but written into the order form: your logo, a quote from you, one recorded video inside 120 days of go-live, and two reference calls to peer CMIOs. Can you commit to that, and does comms have to approve it?

  14. Buyer

    Comms will approve it, that's not the issue. The issue is the PO. Our fiscal year turns July 1 and honestly, my instinct is to push this into next year's budget where it's cleaner. Nothing personal — I'd just rather not fight the finance committee in May.

  15. Rep

    That's your call and I'll still be here. But before you decide — EHR governance meets monthly, so a July PO means an August packet, which means go-live in the fall and your first full specialty wave in Q1. Maria, your third-next-available target and your slot fill numbers were partly built on this landing. And Dr. Reyes, you named three family medicine docs you're worried about losing this year. Does the retention case survive a six-month slip? If it's purely the budget year, I can solve that without either of us losing anything: sign by the 26th, first invoice dated July 1, go-live waves start in June. You get this price, the spend lands in FY26, and your governance packet goes in on the current cycle.

  16. Buyer

    ...That actually helps. If you can hold $130 with the deferred invoice, I can take that to the Medical Group President this week. But I want the implementation fee gone too.

  17. Rep

    I can waive implementation — but it goes with the date, not without it. So: $130 per provider per month, 340 providers, 36 months, annual prepay invoiced July 1, implementation waived, 4% renewal uplift cap, case study and two reference calls inside 120 days of go-live, signature by the 26th. Have I got that right? I'll send the revised order form within the hour. And to be straight with you — that number is tied to those terms and that date. If the 26th moves, I have to re-approve it, and I'd rather say that now than surprise you in three weeks.

Objections you will hear

What they say, and what you say back.

ObjectionHow to answer it
Our operating margin is 1.8%. There's no capital for anything that isn't billing or compliance.Don't defend the price — move onto a P&L line they already own. Two levers work in a medical group: retention and throughput. "You told me turnover is running around 12% and one family medicine departure is six figures in recruiting plus 12 to 18 months of panel ramp. How many providers are on your watch list this year? And separately — if a provider recovers 45 minutes a day, that's one to two more visits. What's your average contribution margin per encounter?" Make them do the arithmetic out loud with their own numbers. The business case has to end up in their handwriting, not your deck. And if they still can't fund it from operations, ask whether the physician wellbeing or retention budget is a different line, because it usually is and it usually reports to the Chief Medical Officer, not to finance.
Supply chain benchmarked you. Another system on our EHR is paying less per provider per month, and our GPO has ambient documentation on contract.Take it seriously, then unpack it. "I'd expect that — we do price differently by scope. Can I ask what's in that comparison: is it enterprise across all specialties or a primary care cohort, is it multi-year, and is implementation inside the PPPM or a separate services line? Those three things move the number more than anything else." Then trade rather than match: "If you want that PPPM, I can get close to it — on the same terms that produced it. Thirty-six months, prepaid, all 340 providers, no phased opt-in. If we're comparing a three-year enterprise agreement to a one-year pilot, we're not comparing anything." Never say the other system got a worse deal. Say they bought a different shape of deal.
We'd rather start with 60 providers in primary care and expand next year — obviously at a much lower total number.This is a price cut dressed as a rollout plan, and it also happens to be the thing that killed their last scribe vendor. Say so. "I'll do it, but let me tell you what I've watched happen. When half the medical staff has it and half doesn't, the have-nots stop believing it's real and the medical executive committee treats it as another pilot. You told me you've already got a scribe vendor in the graveyard." Then offer the structural version instead: "Enterprise scope, enterprise price, but the go-live waves are phased — primary care in June, ortho and derm in September, behavioral health in November — and you only start paying for a wave when it's live. You get the cash curve you want without the two-tier medical staff."
Half our docs abandoned the last scribe vendor after a month. We'll only pay for active users — price it on utilization.Don't reject it, restructure it. First diagnose: "What actually killed it — turnaround time, note quality, specialty coverage, or was it optional?" It's almost always one of those four. Then own adoption instead of pricing around it: "Here's a better version of what you're asking for. Enterprise price, but we write a utilization threshold into the order form — if we're under 70% weekly active use across the enrolled cohort at day 60, you can terminate for convenience and we'll refund the unused term. We review the number weekly with your Director of Clinical Informatics." A vendor who volunteers the exit gets more trust from a CMIO than one who promises success. Utilization-based pricing, by contrast, makes your revenue depend on their change management, which prices in risk and usually ends up costing them more.
Legal and third-party risk review will take 90 days. We're not paying for a period when nobody's using it.Agree instantly and then use it to set the date. "Completely fair — nobody should pay for a product sitting behind a security review. Two things. One, the BAA is standard and I'll send the completed vendor security questionnaire we've already submitted to two other systems on your EHR today so your risk team starts from a finished document. Two, we set the subscription start at go-live, not at signature. What I need in exchange is the signature now, because the review clock and the EHR governance calendar only start when there's paper." Then ask the question that gives you your close date: "Who owns third-party risk here, and how long did the last clinical vendor actually take to get through?"
Even at that number, this has to go through EHR governance, and they meet monthly. I can't promise the 26th.Never route around governance and never treat it as a stall. Get inside it. "What's in the submission packet — do they need the security attestation, the workflow diagram, and a downtime plan? Who on the committee is the skeptic, and is it a clinical objection or a build-resource objection?" Then arm the champion: one-pager, the peer CMIO reference call scheduled *before* the meeting, and your sponsor co-presenting rather than you presenting. Deals die in governance when the CMIO shows up alone with a vendor deck. On the date itself, separate the two things: "Let's hold the pricing to signature, not to committee. If you sign by the 26th and governance moves the build to the following cycle, the number stands — I just need the paper inside my quarter."

Questions reps ask about this call

How do I handle a health system that anchors on what their EHR vendor will charge for a native module?

Don't dispute the number — dispute the timeline and the coverage. Ask two questions out loud: which of their sites is in the actual release wave and when, and whether the native module covers ortho, derm and behavioral health at launch or primary care only. Most CMIOs can't answer the first and know the answer to the second is primary care. Then frame your price as the cost of the next 18 months: "They'll ship it and it'll be fine for a straightforward note. The question is what your specialists do between now and then, when after-hours EHR time is worst in exactly the specialties the native tool covers last." You're not selling against the EHR forever. You're selling against the gap.

They said 'our margin is under 2%' — is that a real objection or a negotiating line?

Both, which is why arguing with it never works. It's factually true at most health systems and it's also the most effective price lever they own. The move is to stop defending software spend and attach the number to a line they already carry: physician turnover (one avoided family medicine departure is six figures in recruiting plus 12–18 months of panel ramp) or throughput (45 minutes recovered per provider per day against their own contribution margin per encounter). Ask them for both inputs so the math comes out in their handwriting. Also check whether physician wellbeing or retention sits in a different budget line than clinical technology — it often does, and it often reports to the Chief Medical Officer rather than finance.

What should I actually ask for in return for a discount in a healthcare deal?

The most valuable things in this market aren't generic. Ask for: a 36-month term (justified by their own 90–120 day credentialing and multi-wave rollout), annual prepay, enterprise scope instead of a single-pod pilot, a named case study with a spokesperson and a delivery date written into the order form, two reference calls to peer CMIOs on the same EHR, a clean MSA without an uncapped liability rewrite, an introduction to the affiliated network or sister region, and a specific signature date. Peer CMIO references on a matching EHR are the single most valuable non-cash item a health system can give you, and they know it — so price them rather than accepting them as a courtesy.

The buyer says they'll push the PO into next fiscal year. Do I discount to save the quarter?

No. Almost every fiscal-year delay in healthcare is a cash-timing problem, not a decision problem, and it has a structural answer that costs you nothing: sign now, date the first invoice for the new fiscal year, and start go-live waves in between. Before you offer it, make them price the delay themselves — EHR governance meets monthly, so a delayed PO usually means a delayed committee packet, which means a fall go-live and a Q1 specialty rollout, which lands on the VP of Clinical Operations' access targets and the CMO's retention watch list. Let them say that out loud, then hand them the deferred-start structure.

How many concessions should I make on a healthcare pricing negotiation call?

Three at most, each smaller than the last, each traded, each explained. A ladder like 8% for a 36-month term, 11% for annual prepay, 12% for signature by a named date is a ladder that sounds like it has a floor. Equal or growing steps — 10, 15, 20 — teach a supply chain lead that the next ask is worth another five points, and they will make it. Discount the implementation and enablement lines before you discount the per-provider-per-month rate, because that PPPM figure is the baseline your renewal uplift is measured against in three years.

They've gone silent after naming a per-provider-per-month figure. What do I say?

Nothing, for about seven seconds. Then ask a question — never improve your own offer twice in a row. "What's driving that number specifically?" or "Is that an approved line or a target?" or, if you need to move the call forward, ask about process instead of price: "What's the approval path once we agree the number — does this go to value analysis, or straight to the Medical Group President?" The silence is deliberate and it's the cheapest tactic on the call. Reps who fill it with "...I could probably get that approved" have paid for a pause.